Neurocrine Biosciences Inc

Rhenman & Partners Asset Management AB NBIX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/14/2026

Shares

100,841

Value ($000)

13,285

Weight

1.6%

2025 Q2 - 2026 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/14/2026	13,285	1.6%	100,841	3/31/2026
2025 Q4	2/13/2026	17,798	1.7%	125,491	12/31/2025
2025 Q3	11/13/2025	16,104	1.8%	114,717	9/30/2025
2025 Q2	8/13/2025	18,755	2.4%	149,217	6/30/2025